Drug profile · INN
aflibercept-boav
EYDENZELT
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
aflibercept-boav (EYDENZELT) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN aflibercept-boav
Brand EYDENZELT
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is aflibercept-boav?
aflibercept-boav (EYDENZELT) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for aflibercept-boav?
EYDENZELT is a marketed brand name for aflibercept-boav. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of aflibercept-boav?
aflibercept-boav has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.